1.41 USD
↘ 0.01 (0.36%)LIVE (AS OF 02:26 PM EST)
Pyxis Oncology, Inc. Common Stock (PYXS) is currently trading at $1.41. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation front, PYXS trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Nov 16, 2026.